<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Iran J Radiol</JournalTitle>
            <Issn>2008-2711</Issn>
            <Volume>15</Volume>
            <Issue>3</Issue>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubDate>
            <journal_id_doi>10.5812/iranjradiol.63270</journal_id_doi>
        </Journal>
        <title locale="en_US">Relationship between the Computed Tomography - Measured Initial Primary Tumor Volume, Urine VMA Level and Stage in Neuroblastoma Patients</title>
        <AuthorList>
            <Author>
                <FirstName>Chih - Chen</FirstName>
                <LastName>Chang</LastName>
            </Author>
            <Author>
                <FirstName>Tang - Her</FirstName>
                <LastName>Jaing</LastName>
            </Author>
            <Author>
                <FirstName>Tsung - Yen</FirstName>
                <LastName>Chang</LastName>
            </Author>
            <Author>
                <FirstName>Chao - Jan</FirstName>
                <LastName>Wang</LastName>
            </Author>
            <Author>
                <FirstName>Wendy</FirstName>
                <LastName>Yang</LastName>
            </Author>
            <Author>
                <FirstName>Chee - Jen</FirstName>
                <LastName>Chang</LastName>
            </Author>
            <Author>
                <FirstName>Shih - Hsiang</FirstName>
                <LastName>Chen</LastName>
            </Author>
        </AuthorList>
        <ArticleType>Research Article</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>5</Month>
                <Day>16</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>26</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Background : Nowadays, volumetric data acquisition has allowed for the accurate quantification of volumetric tumor burden. However, few studies have focused on the relationship between neuroblastoma tumor volume and relevant clinical parameters. Objectives : The purpose of this study was to investigate the relationship of initial computed tomography - measured primary tumor volume (CT
        <sub>PTV</sub>) with 24 - hour urine vanillylmandelic acid (VMA) level and stage in patients with neuroblastoma. Patients and Methods : This retrospective study included 24 patients. The patients’ age, gender, urine VMA levels and stage at diagnosis were collected, and the CT
        <sub>PTVs</sub>were calculated. The correlation between urine VMA level and CT
        <sub>PTV</sub>was assessed. The differences in CT
        <sub>PTVs</sub>with respect to age of the patients (≤ 1.5 and &gt; 1.5 years old), gender, urine VMA levels (≤ 9.8 and &gt; 9.8 mg/24 hours) and stage (stage 4 and non - stage 4) were analyzed. Multivariate linear regression was conducted to estimate the effect of age, gender, urine VMA level, and stage at diagnosis for CT
        <sub>PTV</sub>. Finally, a comparison of demographic characteristics and stage between various CT
        <sub>PTV</sub>ranges (&lt; 35 and ≥ 35 cm
        <sup>3</sup>) was performed. Results : A moderate correlation was observed between urine VMA level and CT
        <sub>PTV</sub>in patients with neuroblastoma (r = 0.673). The median CT
        <sub>PTVs</sub>were significantly larger in patients with urine VMA &gt; 9.8 mg (P = 0.03) and in patients who were diagnosed with stage 4 (P = 0.002). The most effective variable for CT
        <sub>PTV</sub>was urine VMA level. When the urine VMA level increases 1 mg every 24 hours, the CT
        <sub>PTV</sub>will increase 4.85 cm
        <sup>3</sup>. Among the patients with a CT
        <sub>PTV</sub>≥ 35 cm
        <sup>3</sup>, the median age was significantly higher (P = 0.011), and median urine VMA level was significantly higher (P = 0.001) than in patients with a CT
        <sub>PTV</sub>&lt; 35 cm
        <sup>3</sup>. Additionally, all patients with a CT
        <sub>PTV</sub>≥ 35 cm
        <sup>3</sup>had stage 4 disease at the time of diagnosis (P = 0.001). Conclusion : A moderate positive quantitative correlation was observed between 24 - hour urine VMA levels and initial CT
        <sub>PTV</sub>. A CT
        <sub>PTV</sub>≥ 35 cm
        <sup>3</sup>may therefore be used as an indicator of advanced tumor stage in neuroblastoma.</abstract>
        <web_url>http://iranjradiol.com/en/articles/63270.html</web_url>
        <pdf_url>https://cdn.neoscriber.org/cdn/dl/1333cb14-aa3b-11e8-b783-5f56c6ce44b7</pdf_url>
    </Article>
</Articles>
